Multiple Myeloma | Clinical

test

Efebera Discusses Different Regimens for Transplant-Eligible NDMM

November 23, 2022

During a Targeted Oncology case-based roundtable event, Yvonne A. Efebara, MD, MPH, discussed the role of triplet and quadruplet systemic therapies for newly diagnosed multiple myeloma and the use of autologous stem cell transplant.